Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2012
05/18/2012WO2012014085A3 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses
05/18/2012WO2011147034A8 Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
05/17/2012US20120122949 Ultra-high strength injectable hydrogel and process for producing the same
05/17/2012US20120122943 Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
05/17/2012US20120122941 Cycloalkylamine derivatives
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122812 Anti-aging agent
05/17/2012US20120122791 Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate
05/17/2012US20120122790 Methods for the treatment of x-linked hypophosphatemia and related disorders
05/17/2012US20120122785 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122781 Peptide ligands of somatostatin receptors
05/17/2012US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels
05/17/2012US20120122778 Modified TGF-beta superfamily protein
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122767 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121721 Skin care products and compositions
05/17/2012US20120121719 Methods of making and using three-dimensional extracellular matrices
05/17/2012US20120121699 Lycopene and resveratrol dietary supplement
05/17/2012US20120121689 Small interfering rna delivery
05/17/2012US20120121682 cRGD PEPTIDE DERIVATIVE AND ITS MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING A cRGD PEPTIDE DERIVATIVE
05/17/2012US20120121660 Bone void fillers
05/17/2012US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121576 Actriia binding agents and uses thereof
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121555 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121545 Pharmaceutical Composition For Bone Disease Treatment Or Countering Inflammation, Comprising Cartilage Stem Cells As An Active Principle
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452939A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/16/2012EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
05/16/2012EP2451788A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl]-benzoylamino} -4-methylen -penta nedioic acid
05/16/2012EP2268628B1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
05/16/2012EP2183247B1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl]1h- indole- 5 -carbonitrile citrate
05/16/2012EP2125009B1 Medicinal formulation containing a combination of hiv type i and hiv type ii
05/16/2012EP2124919B1 5,5'-(sulfonyldiemethylene)diuracil for modulating bone formation and mineralization
05/16/2012EP2046798B1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
05/16/2012EP2043646B1 (E)-N-{3-(8-Chloro-11H-10-oxa-1-aza- dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-phenyl} -methanesulfonamide as a GLUCOCORTICOID RECEPTOR MODULATOR AND METHODS OF USE
05/16/2012EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient
05/16/2012EP1480993B2 Desaturase genes, enzymes encoded thereby, and uses thereof
05/16/2012CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/16/2012CN102459588A Aptamer for chymase, and use thereof
05/16/2012CN102459577A 适合临床应用于免疫介导性疾病的、具有增强型抑制功能的调节性t细胞的体外扩增方法 Suitable for clinical application of immune-mediated diseases, with enhanced suppression function of regulatory t-cells in vitro amplification methods
05/16/2012CN102459270A Janus激酶3的哌啶抑制剂 Janus kinase 3 inhibitor piperidine
05/16/2012CN102459221A 噻吩衍生物 Thiophene derivative
05/16/2012CN102459142A Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/16/2012CN102458464A New methods for treatment of inflammatory diseases
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN102458421A Medicinal agent
05/16/2012CN102453050A Bisphosphonate compound and preparation method thereof
05/16/2012CN102451462A Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny
05/16/2012CN102451461A Traditional Chinese medicine (TCM) for treating hyperosteogeny
05/16/2012CN102451441A Chinese medicinal composition for treating cold heumatism, diminishing inflammation, reducing swelling and alleviating pain and preparation method thereof
05/16/2012CN102451428A Chinese medicinal composition for treating rheumatoid arthritis
05/16/2012CN102451406A Traditional Chinese medicine for treating rheumatism
05/16/2012CN102451386A Medicament for treating lumbar disc protrusion
05/16/2012CN102451384A Chinese medicinal composition for treating rheumatic arthritis
05/16/2012CN102451378A Uterus health capsule for treating gynopathy
05/16/2012CN102451370A Traditional Chinese medicine wine for treating rheumatism and impediment pain
05/16/2012CN102451346A Medicinal liquor for diminishing inflammation, and preparation method thereof
05/16/2012CN102451340A Traditional Chinese medicine foot bath prescription for treating gout
05/16/2012CN102451294A Preparation method for Chinese herbal Xitong dropping pill
05/16/2012CN102451289A Preparation method for medlar-chrysanthemum wine
05/16/2012CN102451287A External traditional Chinese medicine foot bath medicament for treating gout and preparation method thereof
05/16/2012CN102451252A Traditional Chinese preparation for treating rheumatism
05/16/2012CN102451240A Chinese medicinal composition for treating osteoporosis
05/16/2012CN102451237A Bone joint disease recovery pharmaceutical composition and clinical application
05/16/2012CN102451219A Fermented soya bean active substance and preparation method thereof
05/16/2012CN102451210A Extraction method of effective ingredients from epimedium
05/16/2012CN102451208A Extraction technology of Chinese herbal medicine
05/16/2012CN102450774A Health-care insole
05/16/2012CN102058687B Qingpeng oral formulation for easing pain and reducing swelling and preparation method thereof
05/16/2012CN101904910B Pharmaceutical composition for anti-inflammation and analgesia or anti-inflammation and immunization, and preparation method and use thereof
05/16/2012CN101897766B Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof
05/16/2012CN101696243B Human genetic engineering antibody TRD 109 as well as preparation method and application thereof
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/16/2012CN101228127B Novel piperidine derivative
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 820